2017 annual financial data
Aytu BioPharma 2017 Net margin
Aytu BioPharma 2017 net margin with verified reported values.
Direct answer
Net margin was -698.67%.
Operating income was -20,125,236 USD and net income was -22,508,304 USD.
Operating cash flow was -13,829,652 USD.
Get free Aytu BioPharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,221,590 USD
- Operating income
- -20,125,236 USD
- Net income
- -22,508,304 USD
- Operating cash flow
- -13,829,652 USD